共 50 条
- [21] BRAFv600E INHIBITOR(VEMURAFENIB) IN PEDIATRIC PATIENTS AFFECTED BY BRAFv600E MUTATED GLIOMAS[J]. NEURO-ONCOLOGY, 2016, 18 : 24 - 24del Bufalo, FrancescaCacchione, AntonellaCarai, AndreaAntonelli, ManilaGiangaspero, FeliceFerretti, ElisabettaCatanzaro, GiuseppinaMiele, EvelinaBadiali, ManuelaPettorini, BenedettaMastronuzzi, Angela
- [22] Response to the combination of dabrafenib, trametinib and osimertinib in a patient with EGFR-mutant NSCLC harboring an acquired BRAFV600E mutation[J]. LUNG CANCER, 2020, 139 : 219 - 220Zhou, FeiZhao, WenchengChen, XiaoxiaZhang, JieZhou, Caicun
- [23] Significant response to dabrafenib in a patient with Erdheim-Chester disease with BRAFV600E mutation[J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (06): : 386 - 388Verschelden, GilVan Laethem, JohanVelkeniers, BrigitteIlsen, BartNoeparast, AmirDe Greve, Jacques
- [24] BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib.[J]. CLINICAL CANCER RESEARCH, 2016, 22DeFazio, AnnaMoujaber, TaniaEtemadmoghadam, DariushKennedy, CatherineChiew, Yoke-EngBalleine, Rosemary L.Saunders, CatherineWain, Gerard V.Dobrovic, AlexanderBowtell, David D. L.Harnett, Paul R.
- [25] BRAFV600E Mutation Status of Involuting and Stable Nevi in Dabrafenib Therapy With or Without Trametinib[J]. JAMA DERMATOLOGY, 2014, 150 (10) : 1079 - 1082McClenahan, PhilLin, Lynlee L.Tan, Jean-MarieFlewell-Smith, RossSchaider, HelmutJagirdar, KastureeAtkinson, VictoriaLambie, DuncanProw, Tarl W.Sturm, Richard A.Soyer, H. Peter
- [26] A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS: PNOC-002[J]. NEURO-ONCOLOGY, 2017, 19 : 188 - 188Nicolaides, TheoNazemi, KellieCrawford, JohnKilburn, LindsayMinturn, JaneGajjar, AmarGauvain, KarenLeary, SarahDhall, GirishAboian, MariamRobinson, GilesMolinaro, AnnetteMueller, SabinePrados, Michael
- [27] PNA as novel targeted cancer therapy for BRAFV600E mutant melanoma[J]. CANCER RESEARCH, 2014, 74 (19)Rothman, Jeffrey H.Surriga, OliverVasudeva, Shyamprasad D.Ambrosini, GraziaOuerfelli, OuathekSchwartz, Gary K.
- [28] The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer[J]. CANCERS, 2021, 13 (01) : 1 - 15Mauri, GianlucaBonazzina, EricaAmatu, AlessioTosi, FedericaBencardino, KatiaGori, VivianaMassihnia, DanielaCipani, TizianaSpina, FrancescoGhezzi, SilviaSiena, SalvatoreSartore-Bianchi, Andrea
- [29] MAPK PATHWAY BLOCKADE PRIMES BRAFV600E MUTANT GLIOMA FOR IMMUNOTHERAPY[J]. NEURO-ONCOLOGY, 2016, 18 : 90 - 90Grossauer, StefanKoeck, KatharinaMurphy, NicolePhillips, JoannaWrainwright, DerekOkada, HidehoMueller, SabineJames, C. DavidNicolaides, TheoPetritsch, Claudia K.
- [30] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma[J]. British Journal of Cancer, 2013, 108 : 924 - 931J S WilmottA M MenziesL E HayduD CapperM PreusserY E ZhangJ F ThompsonR F KeffordA von DeimlingR A ScolyerG V Long